CGTX Cognition Therapeutics Buxgalteriya kapitallashuvi

Ommaviy kompaniya Cognition Therapeutics, Inc. (CGTX) logotipi

Cognition Therapeutics (CGTX) AQSh hukumati ko'magi va patent himoyasiga tayangan holda, neyron degradatsiyasiga qarshi kurashish uchun oral terapiyalarni ishlab chiqadi. Biznes bozor sikllaridan mustaqil qolmoqda, chunki uning trayektoriyasi klinik sinovlar natijalari bilan belgilanadi va joriy ko'rsatkich 0.03 darajasida turibdi. Altsgeymer kasalligi uchun sinapslarni himoya qilish ma'lumotlariga bo'lgan kutishlar spekulyatsiyalarni kuchaytirmoqda. Ushbu kunlik narxlar grafigi mazkur fundamental omillarning ta'sirini tasdiqlaydi.

CGTX Cognition Therapeutics, Inc. Balans kapitallashuvi (04.07.2022 - 28.10.2026)

Cognition Therapeutics, Inc. (CGTX) kompaniyasi koʻrsatkichlari kesimi va tahlili

- narx va narxlar bo'yicha konsensus prognoz:
Narx cogrx.com|CGTX - Konsensus maqsadli narx
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor kapitallashuvi Cognition Therapeutics Inc.|CGTX - Kompaniyaning to‘liq qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga xususiy kapital Cognition Therapeutics|CGTX - Balans kapitallashuvi|Bozor qiymatining balans qiymatiga koeffitsiyenti cogrx.com|CGTX - Kompaniyaning yakuniy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati Cognition Therapeutics|CGTX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati Cognition Therapeutics Inc.|CGTX - Kompaniya qarzlari|Balans qiymatiga qarzlar Cognition Therapeutics Inc.|CGTX - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli majburiyatlari Cognition Therapeutics
Kompaniyaning jamlanma tahlili:CGTX - cogrx.com
cogrx.com yetakchi tovari

Balans qiymati kompaniyaning sof aktivlar qiymatining fundamental ko'rsatkichi hisoblanadi. Balans qiymatini tahlil qilish orqali investor barcha majburiyatlar ayirilgandan keyingi haqiqiy kapital miqdorini baholaydi. Ushbu metrika aksiyadorlar ixtiyoridagi kompaniyaning haqiqiy resurslarini aks ettiradi. Cognition Therapeutics (CGTX) uchun ushbu raqam, biznesning yagona dori vositasi sinovlari natijasiga kritik bog'liqligini hisobga olgan holda, moliyaviy yostiq vazifasini o'taydi. Yuqori balans qiymati tor doiradagi ixtisoslashgan klinik portfel bilan bog'liq ikkilik xatarlarni yumshatadi.

Toʻgʻridan-toʻgʻri raqobatchilar

Biogen Idec (BIIB) - Jami sof aktivlar|Kompaniyaning sof aktivlari Neurocrine Biosciences|RGC (regencellbioscience.com) - Buxgalteriya kapitallashuvi|Kompaniyaning balans qiymati Axsome Therapeutics, Inc. (AXSM)|Buxgalteriya kapitallashuvi ACADIA Pharma|Xenon Pharmaceuticals Inc - Balans kapitallashuvi|Kompaniyaning xususiy kapitali Viking Therapeutics Corp VKTX|Kompaniyaning sof aktivlari SUPN (Supernus Pharmaceuticals)|catalystpharma.com - Balans kapitallashuvi|Kompaniyaning balans qiymati Denali Therapeutics Inc. (DNLI)|HRMY: Kompaniyaning buxgalteriya qiymati|Kompaniyaning balans qiymati BHVN|Amylyx Corp (AMLX) - Kompaniyaning xususiy kapitali|Balans kapitallashuvi TRVI|Kompaniyaning sof aktivlari PRAX|Anavex Life Sciences Corp. - Kompaniyaning balans qiymati|Kompaniyaning xususiy kapitali CeriBell Inc (CBLL)|PRTA (prothena.com) - Balans kapitallashuvi|Alector Inc. - Biznesning balans qiymati|Annexon, Inc. (ANNX) - Kompaniyaning balans qiymati|OMER - Buxgalteriya kapitallashuvi|Neurogene - Balans kapitallashuvi|Biznesning balans bahosi AC Immune S.A.|Voyager Pharma (VYGR) - Kompaniyaning sof aktivlari|Jami sof aktivlar Neumora Corp|SCLX (Scilex Holding Company) - Balans kapitallashuvi|Biznesning balans bahosi TVGN (tevogen.com)|ACOG: Kompaniyaning balans qiymati|Inhibikase Therapeutics Inc - Kompaniyaning xususiy kapitali|Cassava (SAVA) - Kompaniyaning balans qiymati|Assertio Holdings, Inc. (ASRT) - Buxgalteriya kapitallashuvi|Kompaniyaning sof aktivlari coyatherapeutics.com COYA|Kompaniyaning buxgalteriya qiymati Vistagen|Ovid Therapeutics Inc (OVID) - Kompaniyaning sof aktivlari|Jami sof aktivlar Acumen Pharmaceuticals Inc.|CervoMed Inc (CRVO) - Balans kapitallashuvi|Kompaniyaning buxgalteriya qiymati alteritytherapeutics.com (ATHE)|CLNN: Balans kapitallashuvi|PepGen Inc - Kompaniyaning xususiy kapitali|Kompaniyaning balans qiymati Jupiter Neurosciences Inc (JUNS)|RLMD - Kompaniyaning buxgalteriya qiymati|ANVS: Balans kapitallashuvi|GRCE (Grace Therapeutics) - Balans kapitallashuvi|Kompaniyaning balans qiymati Firefly Neuroscience, Inc AIFF|Sof aktivlar qiymati ANEW Medical, Inc.|NeuroSense Therapeutics - Balans kapitallashuvi|Kompaniyaning xususiy kapitali Reviva Pharmaceuticals Holdings Inc. RVPH|Kompaniyaning sof aktivlari MTVA (MetaVia)|NRXS - Balans kapitallashuvi|Kompaniyaning sof aktivlari Helius Medical Technologies Inc. HSDT|PASG - Jami sof aktivlar|bionomics.com.au - Balans kapitallashuvi|Minerva Neurosciences Inc (NERV) - Biznesning balans bahosi|Balans kapitallashuvi ATHA|Kompaniyaning sof aktivlari ADXN|ALZN (Alzamend Neuro, Inc.) - Kompaniyaning balans qiymati|Biznesning balans bahosi cyclerion.com (CYCN)|Protagenic Therapeutics, Inc. - Balans kapitallashuvi|Kompaniyaning sof aktivlari Pasithea Therapeutics Corp KTTA|Balans kapitallashuvi CRGT|Avenue Therapeutics Inc (ATXI) - Biznesning balans qiymati|BCLI - Kompaniyaning sof aktivlari|Jami sof aktivlar caratherapeutics.com|Kompaniyaning sof aktivlari Chromocell Therapeutics Corp. (CHRO)|Buxgalteriya kapitallashuvi ELYM|Kompaniyaning balans qiymati Intra-Cellular Therapies ITCI|Buxgalteriya kapitallashuvi Longboard (LBPH)|MRNS: Balans kapitallashuvi|NKGN - Kompaniyaning xususiy kapitali|NeuroBo Pharmaceuticals, Inc. - Kompaniyaning sof aktivlari|SAGE: Balans kapitallashuvi|Kompaniyaning balans qiymati Neurotrope SNPX|TRVN (Trevena Inc) - Kompaniyaning buxgalteriya qiymati|Kompaniyaning balans qiymati VIGL (Vigil Neuroscience Inc.)|Kompaniyaning xususiy kapitali Anew Medical Inc.|Balans kapitallashuvi CERE (Cerevel Therapeutics, Inc.)